Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.6K
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

9.9K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
9.9K
Xylem and Transpiration-driven Transport of Resources02:03

Xylem and Transpiration-driven Transport of Resources

26.8K
The xylem of vascular plants distributes water and dissolved minerals that are taken up by the roots to the rest of the plant. The cells that transport xylem sap are dead upon maturity, and the movement of xylem sap is a passive process.
26.8K
ATP Driven Pumps II: P-type Pumps01:34

ATP Driven Pumps II: P-type Pumps

6.4K
The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
6.4K
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

4.9K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
4.9K
Electromotive Force02:36

Electromotive Force

30.2K
Electricity is generated by either electrons or ions flowing through a solution or a conducting medium. This flow of electrons or specifically electrical charge is defined as an electric current. When electrons move through a wire, they generate an electric current. It can be recalled  that in a redox reaction, electrons are lost and gained. In the spontaneous redox reaction of zinc  with copper, when zinc is immersed in a copper ion solution, a transfer of electrons from one substance to...
30.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Apoptotic effects of mahanine on human leukemic cells are mediated through crosstalk between Apo-1/Fas signaling and the Bid protein and via mitochondrial pathways" [Biochem. Pharmacol. 79 (2010) 361-372].

Biochemical pharmacology·2023
Same author

ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization.

Cancers·2023
Same author

Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation.

Frontiers in genetics·2022
Same author

KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer.

Cancers·2021
Same author

Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling.

Nature communications·2020
Same author

EnABLing Tumor Growth and Progression: Recent progress in unraveling the functions of ABL kinases in solid tumor cells.

Current pharmacology reports·2019

Related Experiment Video

Updated: Feb 4, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

EnABLing Cathepsin-Driven Melanoma Metastasis.

Rakshamani Tripathi1, Rina Plattner1

  • 1Department of Pharmacology and Nutritional Sciences, University of Kentucky School of Medicine, Lexington, Kentucky.

Molecular & Cellular Oncology
|September 26, 2018
PubMed
Summary

Metastatic melanoma is aggressive and hard to cure. New research shows ABL kinases drive cancer spread by increasing cathepsin secretion, suggesting ABL inhibitors could be effective treatments.

Keywords:
ABL1ABL2AblArgETS1NF-κBRELASP1cathepsincysteine cathepsins

More Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K
Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

20.9K

Related Experiment Videos

Last Updated: Feb 4, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K
Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

20.9K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Metastatic melanoma is a deadly cancer with limited treatment options.
  • Secreted cathepsins are key players in promoting cancer metastasis.
  • Understanding the regulation of cathepsin secretion is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the role of ABL kinases in regulating cathepsin secretion in metastatic melanoma.
  • To identify the molecular pathways involved in ABL kinase-mediated cathepsin secretion.
  • To explore the potential of ABL inhibitors as a therapeutic strategy against melanoma metastasis.

Main Methods:

  • Analysis of gene expression and protein levels related to cathepsins and ABL kinases.
  • Investigation of signaling pathways, including ETS1, SP1, and RELA.
  • In vitro and in vivo models of melanoma metastasis.

Main Results:

  • ABL kinases were found to induce cathepsin secretion.
  • Activation of ETS1, SP1, and RELA pathways by ABL kinases mediates this effect.
  • This mechanism contributes to melanoma cell invasion and metastasis.

Conclusions:

  • ABL kinases are critical regulators of cathepsin secretion in metastatic melanoma.
  • Targeting ABL kinases with inhibitors may represent a novel therapeutic approach to block melanoma metastasis.
  • Further research into ABL kinase inhibitors could lead to improved treatments for advanced melanoma.